Journal articleJ Clin Pathol · January 19, 2026
AIMS: Despite continually improving guidelines, human epidermal growth factor receptor 2 (HER2) testing for breast and gastro-oesophageal carcinoma continues to be a technical challenge in clinical laboratories. Manual HER2 fluorescence in situ hybridisati ...
Full textLink to itemCite
Journal articleSemin Diagn Pathol · November 2025
Pancreatic neuroendocrine neoplasms (PanNENs) are broadly divided into well-differentiated pancreatic neuroendocrine tumors (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs). Grading is based on the mitotic count and Ki-67 ...
Full textLink to itemCite
Journal articleAnn Diagn Pathol · February 2025
Patients with 22q11.2 deletion syndrome or DiGeorge syndrome commonly report gastrointestinal symptoms in addition to more widely understood cardiac and immunodeficiency abnormalities. However, the morphologic features of gastrointestinal tract pathology i ...
Full textLink to itemCite